Molecular Partners AG
NASDAQ:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
NASDAQ:MOLN
Watchlist
Price: 5.08 USD -2.68% Market Closed
Market Cap: 168.6m USD
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 12.56 USD with a low forecast of 7.91 USD and a high forecast of 17.63 USD.

Lowest
Price Target
7.91 USD
56% Upside
Average
Price Target
12.56 USD
147% Upside
Highest
Price Target
17.63 USD
247% Upside
Molecular Partners AG Competitors:
Price Targets
SANION
Saniona AB
25% Downside
RPTX
Repare Therapeutics Inc
866% Upside
GLUE
Monte Rosa Therapeutics Inc
142% Upside
MAB
Mabion SA
37% Upside
LTRN
Lantern Pharma Inc.
614% Upside
006280
Green Cross Corp
15% Upside
ASND
Ascendis Pharma A/S
44% Upside
4599
StemRIM Inc
134% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 4 years is 83%.

-16%
Past Growth
83%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
12.56 USD

According to Wall Street analysts, the average 1-year price target for MOLN is 12.56 USD with a low forecast of 7.91 USD and a high forecast of 17.63 USD.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
83%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 4 years is 83%.

Back to Top